Physician's Weekly

JUNE 17, 2025

The FDA sent a warning letter to the maker of a product called Tianna in 2018. Between 2018 and 2023, tianeptine-related calls to U.S. .” And, the U.S. Food and Drug Administration (FDA) warns that they pose similar risks of addiction and life-threatening side effects. Amid a rise in calls to U.S.

Medical 52

Medical IT Hospital Government 52

Physician's Weekly

JUNE 25, 2025

Insurance companies have promised changes like these before, in 2018 and 2023, but many didn’t follow through, Dr. Mehmet Oz , head of the Centers for Medicare & Medicaid Services (CMS), said. But experts say the changes may not go far enough. Mehmet Oz , head of the Centers for Medicare & Medicaid Services (CMS), said.

Insurance 52

Insurance Patient-Centered Electronics Physicals 52

Physician's Weekly

JUNE 25, 2025

Supporters said it was meant to close a legal loophole created in 2018 when a federal law allowed states to regulate hemp, a plant that can be processed to create THC. These products contain tetrahydrocannabinol (THC), the chemical responsible for a marijuana high. Texas is not the only state to reconsider limits on THC consumables.

Medical 52

Medical IT Family Practice Internal Medicine 52